SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
ADIAL PHARMACEUTICALS, INC.
@ADIL_InsiderForm 4 Filing: Coastlands Capital LP Buys $32,637.87 of $ADIL
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
ADIAL PHARMACEUTICALS, INC.
Ticker: $ADIL
Transaction Value
$32,637.87
Price/Share: $2.78
transaction date
2026-07-09
Shares: 11,753
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Coastlands Capital LP, holds the title of 10% Owner at ADIAL PHARMACEUTICALS, INC..
On 2026-07-09, the insider transacted 11,753 shares.The shares were transacted at a weighted average price of $2.78 per share, resulting in a total market-relevant value of $32,637.87.
Executive Summary Summary
Coastlands Capital LP (10% Owner) bought $33K of $ADIL
Post-Transaction Position: 383,375 shares
SEC Accession No: 0001104659-26-082972 (CIK: 2068530)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.